
WHF Recommendations for the Use of Echocardiography in Chagas Disease
References
- Echeverría LE, Marcus R, Novick G, Sosa-Estani S, Ralston K, Zaidel EJ, et al. WHF IASC Roadmap on Chagas Disease. Glob Heart. 2020; 15(1): 26. DOI: 10.5334/gh.484
- Ribeiro AL, Marcolino MS, Prineas RJ, Lima-Costa MF. Electrocardiographic abnormalities in elderly Chagas disease patients: 10-year follow-up of the Bambui Cohort Study of Aging. J Am Heart Assoc. 2014; 3(1):
e000632 . DOI: 10.1161/JAHA.113.000632 - Acquatella H, Asch FM, Barbosa MM, Barros M, Bern C, Cavalcante JL, et al. Recommendations for Multimodality Cardiac Imaging in Patients with Chagas Disease: A Report from the American Society of Echocardiography in Collaboration With the InterAmerican Association of Echocardiography (ECOSIAC) and the Cardiovascular Imaging Department of the Brazilian Society of Cardiology (DIC-SBC). J Am Soc Echocardiogr. 2018; 31(1): 3–25. DOI: 10.1016/j.echo.2017.10.019
- Yadav H, Shah D, Sayed S, Horton S, Schroeder LF. Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys. Lancet Glob Health. 2021; 9(11): e1553–e60. DOI: 10.1016/S2214-109X(21)00442-3
- Norman D, Olaf H. An experimental application of the DELPHI method to the use of experts. Manag Sci. 1963; 9(3): 458–67. DOI: 10.1287/mnsc.9.3.458
- Patel MR, Spertus JA, Brindis RG, Hendel RC, Douglas PS, Peterson ED, et al. ACCF proposed method for evaluating the appropriateness of cardiovascular imaging. J Am Coll Cardiol. 2005; 46(8): 1606–13. DOI: 10.1016/j.jacc.2005.08.030
- Rassi A,
Jr , Rassi A, Marin-Neto JA. Chagas disease. The Lancet. 2010; 375(9723): 1388–402. DOI: 10.1016/S0140-6736(10)60061-X - Nunes MCP, Beaton A, Acquatella H, Bern C, Bolger AF, Echeverría LE, et al. Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association. Circulation. 2018; 138(12): e169–e209. DOI: 10.1161/CIR.0000000000000599
- Navarro M, Navaza B, Guionnet A, López-Vélez R. Chagas disease in Spain: need for further public health measures. PLoS Negl Trop Dis. 2012; 6(12):
e1962 . DOI: 10.1371/journal.pntd.0001962 - Lima NA, Martin DT, de Castro RL, Ladzinski A, Ring A, Vos D, et al. Hospitalization for Chagas Heart Disease in the United States From 2002 to 2017. JAMA Netw Open. 2021; 4(10):
e2129959 . DOI: 10.1001/jamanetworkopen.2021.29959 - Gascón J, Albajar P, Cañas E, Flores M, Gómez i Prat J, Herrera RN, et al. Diagnosis, management and treatment of chronic Chagas heart disease in areas where Trypanosoma cruzi infection is not endemic. Rev Esp Cardiol. 2007; 60(3): 285–93.DOI: 10.1157/13100280
- Rassi A, Rassi SG. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation. 2007; 115(9): 1101–8. DOI: 10.1161/CIRCULATIONAHA.106.627265
- Ortiz JV, Pereira BVM, Couceiro KDN, Silva MRHD, Doria SS, Silva PRLD, et al. Cardiac Evaluation in the Acute Phase of Chagas’ Disease with Post-Treatment Evolution in Patients Attended in the State of Amazonas, Brazil. Arq Bras Cardiol. 2019; 112(3): 240–6. DOI: 10.5935/abc.20190007
- Gray EB, La Hoz RM, Green JS, Vikram HR, Benedict T, Rivera H, et al. Reactivation of Chagas disease among heart transplant recipients in the United States, 2012–2016. Transpl Infect Dis. 2018; 20(6):
e12996 . DOI: 10.1111/tid.12996 - Bacal F, Silva CP, Pires PV, Mangini S, Fiorelli AI, Stolf NG and Bocchi EA. Transplantation for Chagas’ disease: an overview of immunosuppression and reactivation in the last two decades. Clin Transplant. 2010; 24(2): E29–E34. DOI: 10.1111/j.1399-0012.2009.01202.x
- Morillo CA, Waskin H, Sosa-Estani S, Del Carmen Bangher M, Cuneo C, Milesi R, et al. Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial. J Am Coll Cardiol. 2017; 69(8): 939–47. DOI: 10.1016/j.jacc.2016.12.023
- Chadalawada S, Sillau S, Archuleta S, Mundo W, Bandali M, Parra-Henao G, et al. Risk of Chronic Cardiomyopathy Among Patients With the Acute Phase or Indeterminate Form of Chagas Disease: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020; 3(8):
e2015072 . DOI: 10.1001/jamanetworkopen.2020.15072 - Andrade JP, Marin Neto JA, Paola AA, Vilas-Boas F, Oliveira GM, Bacal F, et al. I Latin American Guidelines for the diagnosis and treatment of Chagas’ heart disease: executive summary. Arq Bras Cardiol. 2011; 96(6): 434–42. DOI: 10.1590/S0066-782X2011000600002
- Tazar J, Arce Rojas N, Barbosa M. Alteraciones ecocardiográficas precoces en la enfermedad de Chagas crónica sin patología demostrada. Insuficiencia cardíaca. 2017; 12(3): 106–110.
- Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN, Investigators S. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992; 327(10): 685–91. DOI: 10.1056/NEJM199209033271003
- Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, Rassi GG, et al. Development and validation of a risk score for predicting death in Chagas’ heart disease. N Engl J Med. 2006; 355(8): 799–808. DOI: 10.1056/NEJMoa053241
- Acquatella H. Echocardiography in Chagas heart disease. Circulation. 2007; 115(9): 1124–31. DOI: 10.1161/CIRCULATIONAHA.106.627323
- Fernandez AB, Nunes MC, Clark EH, Samuels A, Menacho S, Gomez J, et al. Electrocardiographic and echocardiographic abnormalities in Chagas disease: Findings in residents of rural Bolivian communities hyperendemic for Chagas disease. Glob Heart. 2015; 10(3): 159–66. DOI: 10.1016/j.gheart.2015.07.004
- Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015; 28(1): 1–39.e14. DOI: 10.1016/j.echo.2014.10.003
- Chamsi-Pasha MA, Sengupta PP, Zoghbi WA. Handheld Echocardiography: Current State and Future Perspectives. Circulation. 2017; 136(22): 2178–88. DOI: 10.1161/CIRCULATIONAHA.117.026622
- Becker DM, Tafoya CA, Becker SL, Kruger GH, Tafoya MJ, Becker TK. The use of portable ultrasound devices in low- and middle-income countries: a systematic review of the literature. Trop Med Int Health. 2016; 21(3): 294–311. DOI: 10.1111/tmi.12657
- Parada H, Carrasco HA, Añez N, Fuenmayor C, Inglessis I. Cardiac involvement is a constant finding in acute Chagas‘ disease: a clinical, parasitological and histopathological study. Int J Cardiol. 1997; 60(1): 49–54. DOI: 10.1016/S0167-5273(97)02952-5
- Viotti RJ, Vigliano C, Laucella S, Lococo B, Petti M, Bertocchi G, et al. Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure. Heart. 2004; 90(6): 655–60. DOI: 10.1136/hrt.2003.018960
- Dias JC, Ramos AN, Gontijo ED, Luquetti A, Shikanai-Yasuda MA, Coura JR, et al. 2 nd Brazilian Consensus on Chagas Disease, 2015. Rev Soc Bras Med Trop. 2016; 49Suppl 1(Suppl 1): 3–60. DOI: 10.1590/0037-8682-0504-2016
- Rossi MA. Fibrosis and inflammatory cells in human chronic chagasic myocarditis: scanning electron microscopy and immunohistochemical observations. Int J Cardiol. 1998; 66(2): 183–94. DOI: 10.1016/S0167-5273(98)00208-3
- Barros, MV, Leren, IS, Edvardsen, T, Haugaa, KH, Carmo, AA, Lage, TA, et al. Mechanical Dispersion Assessed by Strain Echocardiography Is Associated with Malignant Arrhythmias in Chagas Cardiomyopathy. J Am Soc Echocardiogr. 2016; 29(4): 368–74. DOI: 10.1016/j.echo.2015.12.008
- García-Álvarez A, Sitges M, Regueiro A, Poyatos S, Jesus Pinazo M, Posada E, et al. Myocardial deformation analysis in Chagas heart disease with the use of speckle tracking echocardiography. J Card Fail. 2011; 17(12): 1028–34. DOI: 10.1016/j.cardfail.2011.08.007
- Gomes VA, Alves GF, Hadlich M, Azevedo CF, Pereira IM, Santos CR, et al. Analysis of Regional Left Ventricular Strain in Patients with Chagas Disease and Normal Left Ventricular Systolic Function. J Am Soc Echocardiogr. 2016; 29(7): 679–88. DOI: 10.1016/j.echo.2016.03.007
- Picard MH, Popp RL, Weyman AE. Assessment of left ventricular function by echocardiography: a technique in evolution. J Am Soc Echocardiogr. 2008; 21(1): 14–21. DOI: 10.1016/j.echo.2007.11.007
- Lang RM, Badano LP, Tsang W, Adams DH, Agricola E, Buck T, et al. EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J Am Soc Echocardiogr. 2012; 25(1): 3–46. DOI: 10.1016/j.echo.2011.11.010
- Nascimento CA, Gomes VA, Silva SK, Santos CR, Chambela MC, Madeira FS, et al. Left atrial and left ventricular diastolic function in chronic Chagas disease. J Am Soc Echocardiogr. 2013; 26(12): 1424–33. DOI: 10.1016/j.echo.2013.08.018
- Menezes Junior ADS, Lopes CC, Cavalcante PF, Martins E. Chronic Chagas Cardiomyopathy Patients and Resynchronization Therapy: a Survival Analysis. Braz J Cardiovasc Surg. 2018; 33(1): 82–8. DOI: 10.21470/1678-9741-2017-0134
- Martinelli Filho M, de Lima Peixoto G, de Siqueira SF, Martins SA, Nishioka SA, Pedrosa AA, et al. A cohort study of cardiac resynchronization therapy in patients with chronic Chagas cardiomyopathy. Europace. 2018; 20(11): 1813–1818. DOI: 10.1093/europace/eux375
- Nunes MC, Dones W, Morillo CA, Encina JJ, Ribeiro AL, Cardiology CoCDotISo. Chagas disease: an overview of clinical and epidemiological aspects. J Am Coll Cardiol. 2013; 62(9): 767–76. DOI: 10.1016/j.jacc.2013.05.046
- Oliveira JS, Mello De Oliveira JA, Frederigue U, Lima Filho EC. Apical aneurysm of Chagas’s heart disease. Br Heart J. 1981; 46(4): 432–7. DOI: 10.1136/hrt.46.4.432
- Nunes MoC, Barbosa MM, Rocha MO. Peculiar aspects of cardiogenic embolism in patients with Chagas’ cardiomyopathy: a transthoracic and transesophageal echocardiographic study. J Am Soc Echocardiogr. 2005; 18(7): 761–7. DOI: 10.1016/j.echo.2005.01.026
- Nunes MCP, Badano LP, Marin-Neto JA, Edvardsen T, Fernández-Golfín C, Bucciarelli-Ducci C, et al. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI). Eur Heart J Cardiovasc Imaging. 2018; 19(4): 459–60n. DOI: 10.1093/ehjci/jex154
- Ribeiro AL, Nunes MP, Teixeira MM, Rocha MO. Diagnosis and management of Chagas disease and cardiomyopathy. Nat Rev Cardiol. 2012; 9(10): 576–89. DOI: 10.1038/nrcardio.2012.109
- Garcia-Alvarez A, Sitges M, Pinazo MJ, Regueiro-Cueva A, Posada E, Poyatos S, et al. Chagas cardiomyopathy: the potential of diastolic dysfunction and brain natriuretic peptide in the early identification of cardiac damage. PLoS Negl Trop Dis. 2010; 4(9):
e826 . DOI: 10.1371/journal.pntd.0000826 - Pazin-Filho A, Romano MM, Gomes Furtado R, de Almeida Filho OC, Schmidt A, Marin-Neto JA, et al. Left ventricular global performance and diastolic function in indeterminate and cardiac forms of Chagas’ disease. J Am Soc Echocardiogr. 2007; 20(12): 1338–43. DOI: 10.1016/j.echo.2007.04.029
- Barbosa MM, Costa Rocha MO, Vidigal DF, Bicalho Carneiro ReC, Araújo RD, Palma MC, et al. Early detection of left ventricular contractility abnormalities by two-dimensional speckle tracking strain in Chagas’ disease. Echocardiography. 2014; 31(5): 623–30. DOI: 10.1111/echo.12426
- Nunes MC, Reis RC, Colosimo EA, Ribeiro AL, Barbosa FB, da Silva JL, et al. Risk estimation approach in Chagas disease is still needed. Int J Cardiol. 2011; 147(2): 294–6. DOI: 10.1016/j.ijcard.2010.12.044
- Nunes MP, Colosimo EA, Reis RC, Barbosa MM, da Silva JL, Barbosa F, et al. Different prognostic impact of the tissue Doppler-derived E/e’ ratio on mortality in Chagas cardiomyopathy patients with heart failure. J Heart Lung Transplant. 2012; 31(6): 634–41. DOI: 10.1016/j.healun.2012.01.865
- Fragata CaS, Matsumoto AY, Ramires FJ, Fernandes F, Buck PeC, Salemi VM, et al. Left Atrial Function in Patients with Chronic Chagasic Cardiomyopathy. Arq Bras Cardiol. 2015; 105(1): 28–36. DOI: 10.5935/abc.20150045
- Nunes MC, Barbosa MM, Ribeiro AL, Colosimo EA, Rocha MO. Left atrial volume provides independent prognostic value in patients with Chagas cardiomyopathy. J Am Soc Echocardiogr. 2009; 22(1): 82–8. DOI: 10.1016/j.echo.2008.11.015
- Mancuso FJ, Almeida DR, Moisés VA, Oliveira WA, Mello ES, Poyares D, et al. Left atrial dysfunction in chagas cardiomyopathy is more severe than in idiopathic dilated cardiomyopathy: a study with real-time three-dimensional echocardiography. J Am Soc Echocardiogr. 2011; 24(5): 526–32. DOI: 10.1016/j.echo.2011.01.013
- Barbosa MM, Rocha MO, Botoni FA, Ribeiro AL, Nunes MC. Is atrial function in Chagas dilated cardiomyopathy more impaired than in idiopathic dilated cardiomyopathy? Eur J Echocardiogr. 2011; 12(9): 643–7. DOI: 10.1093/ejechocard/jer096
- Barros MV, Machado FS, Ribeiro AL, Da Costa Rocha MO. Detection of early right ventricular dysfunction in Chagas’ disease using Doppler tissue imaging. J Am Soc Echocardiogr. 2002; 15(10 Pt 2): 1197–201. DOI: 10.1067/mje.2002.122966
- Furtado RG, Frota DoC, Silva JB, Romano MM, Almeida Filho OC, Schmidt A, et al. Right ventricular Doppler echocardiographic study of indeterminate form of chagas disease. Arq Bras Cardiol. 2015; 104(3): 209–17. DOI: 10.5935/abc.20140197
- Nunes MoC, Barbosa MeM, Brum VA, Rocha MO. Morphofunctional characteristics of the right ventricle in Chagas’ dilated cardiomyopathy. Int J Cardiol. 2004; 94(1): 79–85. DOI: 10.1016/j.ijcard.2003.05.003
- Nunes MoC, Rocha MO, Ribeiro AL, Colosimo EA, Rezende RA, Carmo GA, et al. Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas’ cardiomyopathy. Int J Cardiol. 2008; 127(3): 372–9. DOI: 10.1016/j.ijcard.2007.06.012
- Romano MMD, Moreira HT, Schmidt A, Maciel BC, Marin-Neto JA. Imaging Diagnosis of Right Ventricle Involvement in Chagas Cardiomyopathy. Biomed Res Int. 2017; 2017:
3820191 . DOI: 10.1155/2017/3820191 - Nunes MC, Carmo AA, Rocha MO, Ribeiro AL. Mortality prediction in Chagas heart disease. Expert Rev Cardiovasc Ther. 2012; 10(9): 1173–84. DOI: 10.1586/erc.12.111
- Nunes MoC, Beloti FR, Lima MM, Barbosa MM, Pinto Filho MM, de Barros MV, et al. Functional capacity and right ventricular function in patients with Chagas heart disease. Eur J Echocardiogr. 2010; 11(7): 590–5. DOI: 10.1093/ejechocard/jeq022
- Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022; 43(7): 561–632. DOI: 10.1093/eurheartj/ehab395
- de Almeida EA, Camargo LF, Lopes MA, de Castro Neto P, Salemi VM, Libermann A, et al. Mitral valve prolapse in chronic Chagas patients. Echocardiographic study. Arq Bras Cardiol. 1986; 47(3): 207–10.
- Ramos JM, Torrús D, Amador C, Jover F, Pérez-Chacón F, Ponce Y, et al. Multicenter epidemiological and clinical study on imported Chagas diseases in Alicante, Spain. Pathog Glob Health. 2012; 106(6): 340–5. DOI: 10.1179/2047773212Y.0000000039
- Morillo CA, Marin-Neto JA, Avezum A, Sosa-Estani S, Rassi A, Rosas F, et al. Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy. N Engl J Med. 2015; 373(14): 1295–306. DOI: 10.1056/NEJMoa1507574
- García-Chamorro LG, Zaidel EJ, Gheco L, Oliva MA, de-la-Vega A, Orosco A, et al. First appropriate implantable defibrillator shocks in patients with Chagasic heart disease. Arch Cardiol Mex. 2022; 92(3): 342–8. DOI: 10.24875/ACME.M22000326
- Xavier SS, Sousa AS, Mallet AR, Hasslocher-Moreno A. Progressão da lesão miocardica na doença de Chagas: um estudo ecocardiográfico. Arq Bras Cardiol. 2004; 83(Suppl III): 127.
- McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42(36): 3599–726. DOI: 10.1093/eurheartj/ehab368
- Rochitte CE, Oliveira PF, Andrade JM, Ianni BM, Parga JR, Avila LF, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas’ disease: a marker of disease severity. J Am Coll Cardiol. 2005; 46(8): 1553–8. DOI: 10.1016/j.jacc.2005.06.067
- Romero J, Velasco A, Pisani CF, Alviz I, Briceno D, Díaz JC, et al. Advanced Therapies for Ventricular Arrhythmias in Patients With Chagasic Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021; 77(9): 1225–42. DOI: 10.1016/j.jacc.2020.12.056
- Mello RP, Szarf G, Schvartzman PR, Nakano EM, Espinosa MM, Szejnfeld D, et al. Delayed enhancement cardiac magnetic resonance imaging can identify the risk for ventricular tachycardia in chronic Chagas’ heart disease. Arq Bras Cardiol. 2012; 98(5): 421–30. DOI: 10.1590/S0066-782X2012005000031
- Senra T, Ianni BM, Costa ACP, Mady C, Martinelli-Filho M, Kalil-Filho R, et al. Long-Term Prognostic Value of Myocardial Fibrosis in Patients With Chagas Cardiomyopathy. J Am Coll Cardiol. 2018; 72(21): 2577–87. DOI: 10.1016/j.jacc.2018.08.2195
- Pacheco AB, Melo RJ, Rochitte CE. Cardiac Magnetic Resonance in the Assessment of Chagas Disease and its Complications. Int. J. Cardiovasc. Sci. 2020; 33(6): 705–12. DOI: 10.36660/ijcs.20200250
- Antonio M-NJ, Romano MMD, Maciel BC. Cardiac Imaging in Latin America: Chagas Heart Disease. CurrCardiovasc Imaging Rep. 2015; 8(9). DOI: 10.1007/s12410-015-9324-2
- Marin-Neto JA, Cunha-Neto E, Maciel BC, Simões MV. Pathogenesis of chronic Chagas heart disease. Circulation. 2007; 115(9): 1109–23. DOI: 10.1161/CIRCULATIONAHA.106.624296
- Miranda CH, Figueiredo AB, Maciel BC, Marin-Neto JA, Simões MV. Sustained ventricular tachycardia is associated with regional myocardial sympathetic denervation assessed with 123I-metaiodobenzylguanidine in chronic Chagas cardiomyopathy. J Nucl Med. 2011; 52(4): 504–10. DOI: 10.2967/jnumed.110.082032
- Lemos de Oliveira LF, Thackeray JT, Marin Neto JA, Dias Romano MM, Vieira de Carvalho EE, Mejia J, et al. Regional Myocardial Perfusion Disturbance in Experimental Chronic Chagas Cardiomyopathy. J Nucl Med. 2018; 59(9): 1430–6. DOI: 10.2967/jnumed.117.205450
- Simoes MV, Tanaka DM, Marin-Neto JA. Nuclear Medicine Methods for Assessment of Chronic Chagas Heart Disease. Int. J. Cardiovasc. Sci. 2020; 33(6): 686–9. DOI: 10.36660/ijcs.20200153
DOI: https://doi.org/10.5334/gh.1207 | Journal eISSN: 2211-8179
Language: English
Submitted on: Apr 9, 2023
Accepted on: May 2, 2023
Published on: Jun 8, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2023 Kate Ralston, Ezequiel Zaidel, Harry Acquatella, Marcia Melo Barbosa, Jagat Narula, Yu Nakagama, Gustavo Restrepo Molina, Karen Sliwa, Jose Luis Zamorano, Fausto J. Pinto, Daniel Jose Piñeiro, Mariana Corneli, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.